00:00
Let's talk quickly about fat absorption inhibitors.
00:03
Orlistat which is sold as Xenical is sold as an obesity treatment
but it does have reduction in cholesterol too.
00:12
Now 50% of patients who take orlistat have a 5% reduction in body mass.
00:17
The reduction in diabetes mellitus incidence is also recorded, probably related to weight loss.
00:23
There is a modest reduction in blood pressure and a mild reduction in LDL as well.
00:27
Now this reduction in LDL is actually independent of the weight loss.
00:32
So, whatever LDL reduction you get from weight loss, there seems to be a little bit more.
00:39
The primary serious side effect of Orlistat is an increased risk of renal failure.
00:44
This complication is relatively rare but it is worth mentioning.
00:48
The renal failure is related to an increase in oxalate stone formation.
00:52
The other side effects are generally based around the therapeutic action of the medication.
00:56
For instance patients complain of loose stools and incontinent,
both of which are due to increase fat now being excreted in their stool.
01:04
Luckily, most of these side effects can be significantly reduced by dietary modification.
01:09
Let's move on to the MTP inhibitors.
01:13
They're fiendishly expensive.
01:15
The prototypical drug I would say is lomitapide or Juxtapid. It's an oral tablet.
01:23
Now, it acts on the microsomal triglyceride transfer protein or MTP, and it is inhibitor of that protein.
01:34
VLDL and triglyceride assembly and secretion in the liver is what is being affected here.
01:40
It is used for the treatment of familial hypercholesterolemia.
01:45
And what it does is it reduces VLDL and all of the non-HDL fraction of the cholesterol profile.
01:52
It also will reduce apolipoprotein B, because remember that apolipoprotein B
are these proteins that are going to be attached to either VLDL or LDL.
02:04
It can be used in combination with statins
and some reports indicate up to 60% reduction in LDL cholesterol with these medications.
02:15
The adverse events, it may increase hepatic triglyceride levels and it may cause a transaminitis.